Carl Zeiss Licenses Digital Pathology Patents from Olympus
"The handling of digital data has become a major driver of the development of modern microscopy,” says Dr. Bernhard Ohnesorge, member of the board and general manager, BioSciences Division of Carl Zeiss Microscopy. “Integrating the virtual slide functionality into our research microscope systems will enable our customers to become more efficient and to explore new scientific approaches. This will help them to better understand the root causes of the most challenging diseases.”
“Global adoption of digital slide scanning continues to expand into new medical and scientific applications,” says Brad Burklow, executive director, business development, Scientific Equipment Group, Olympus Corp. of the Americas. “Olympus is the holder of many important patents in this area, and we feel it is vital to allow broad access to these technologies in order to advance the field of pathology and medical research. We are confident that leveraging these technologies will enhance healthcare for patients around the world.”
The companies are not making specific terms and conditions of the agreement public.